The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Open accessAbstract
Cell-based therapies have the potential to make a large contribution toward currently unmet patient need and thus effective manufacture of these products is essential. Many challenges must be overcome before this can become a reality and a better definition of the manufacturing requirements for cell-based products must be obtained. The aim of this study is to inform industry and academia of current cell-based therapy clinical development and to identify gaps in their manufacturing requirements. A total of 1342 active cell-based therapy clinical trials have been identified and characterized based on cell type, target indication and trial phase. Multiple technologies have been assessed for the manufacture of these cell types in order to facilitate product translation and future process development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,073
Embryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.055 · Cited by 1,350
Bianco, P., Cao, X., Frenette, P. S., Mao, J. J., Robey, P. G., Simmons, P. J., & Wang, C.-Y. (2013) · Nature Medicine · doi:10.1038/nm.3028 · Cited by 1,197
Small, E. J., Schellhammer, P. F., Higano, C. S., Redfern, C. H., Nemunaitis, J. J., Valone, F. H., Verjee, S. S., Jones, L. A., & Hershberg, R. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5252 · Cited by 1,108
Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain
Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., & Verfaillie, C. M. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00869-x · Cited by 863
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., & Le Blanc, K. (2012) · Stem Cells · doi:10.1002/stem.1118 · Cited by 577
Lu, B., Malcuit, C., Wang, S., Girman, S., Francis, P., Lemieux, L., Lanza, R., & Lund, R. (2009) · Stem Cells · doi:10.1002/stem.149 · Cited by 470
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Butler, M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1980-8 · Cited by 469
Clinical trials for stem cell therapies
Trounson, A., Thakar, R. G., Lomax, G., & Gibbons, D. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-52 · Cited by 445
Reactor Engineering in Large Scale Animal Cell Culture
Nienow, A. W. (2006) · Cytotechnology · doi:10.1007/s10616-006-9005-8 · Cited by 433
Self-citationMSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 433
Transplantation of Marrow to Extramedullary Sites
Tavassoli, M., & Crosby, W. H. (1968) · Science · doi:10.1126/science.161.3836.54 · Cited by 381
Disposable bioreactor for cell culture using wave-induced agitation
Singh, V. (1999) · Cytotechnology · doi:10.1023/a:1008025016272 · Cited by 303
The Systematic Production of Cells for Cell Therapies
Kirouac, D. C., & Zandstra, P. W. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.001 · Cited by 301
The dark side of induced pluripotency
Pera, M. F. (2011) · Nature · doi:10.1038/471046a · Cited by 269
Scalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264
The Promise and Perils of Stem Cell Therapeutics
Daley, G. Q. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.010 · Cited by 259
Tissue Engineering: The End of the Beginning
Lysaght, M. J., & Hazlehurst, A. L. (2004) · Tissue Engineering · doi:10.1089/107632704322791943 · Cited by 238
Long-term microcarrier suspension cultures of human embryonic stem cells
Oh, S. K. W., Chen, A. K., Mok, Y., Chen, X., Lim, U.-M., Chin, A., Choo, A. B. H., & Reuveny, S. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.02.005 · Cited by 237
Vrábel, P., van der Lans, R. G. J. M., Luyben, K. C. A. M., Boon, L. A., & Nienow, A. W. (2000) · Chemical Engineering Science · doi:10.1016/s0009-2509(00)00175-5 · Cited by 230
Self-citationNew ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research
Hyun, I., Lindvall, O., Ährlund-Richter, L., Cattaneo, E., Cavazzana-Calvo, M., Cossu, G., De Luca, M., Fox, I. J., Gerstle, C., Goldstein, R. A., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.009 · Cited by 229
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., Vorauer‐Uhl, K., Weik, R., Borth, N., Katinger, H., et al. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21013 · Cited by 216
Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor
Rafiq, Q. A., Brosnan, K. M., Coopman, K., Nienow, A. W., & Hewitt, C. J. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1211-9 · Cited by 212
Self-citationBravery, C. A., Carmen, J., Fong, T., Oprea, W., Hoogendoorn, K. H., Woda, J., Burger, S. R., Rowley, J. A., Bonyhadi, M. L., & Van't Hof, W. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.10.008 · Cited by 194
Disposable Bioreactor for Cell Culture Using Wave-Induced Agitation
Singh, V. (2006) · New Developments and New Applications in Animal Cell Technology · doi:10.1007/0-306-46860-3_74 · Cited by 175
Automated, scalable culture of human embryonic stem cells in feeder‐free conditions
Thomas, R. J., Anderson, D., Chandra, A., Smith, N. M., Young, L. E., Williams, D., & Denning, C. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22187 · Cited by 163
A potentially scalable method for the harvesting of hMSCs from microcarriers
Nienow, A. W., Rafiq, Q. A., Coopman, K., & Hewitt, C. J. (2014) · Biochemical Engineering Journal · doi:10.1016/j.bej.2014.02.005 · Cited by 161
Self-citationThe Global Landscape of Stem Cell Clinical Trials
Li, M., Atkins, H. L., & Bubela, T. M. (2013) · Regenerative Medicine · doi:10.2217/rme.13.80 · Cited by 154
Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy
Rowley, J. A., Abraham, E., Campbell, A., Brandwein, H. J., & Oh, S. (2012) · Cited by 141
Viswanathan, S., Keating, A., Deans, R., Hematti, P., Prockop, D. J., Stroncek, D. F., Stacey, G., Weiss, D. J., Mason, C., & Rao, M. S. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0591 · Cited by 137
Nienow, A., Rielly, C., Brosnan, K. M., Bargh, N., Lee, K., Coopman, K., & Hewitt, C. (2013) · Biochemical Engineering Journal · doi:10.1016/j.bej.2013.04.011 · Cited by 127
Self-citationIn-situ microscopy: Online process monitoring of mammalian cell cultures
Joeris, K., Frerichs, J.-G., Konstantinov, K., & Scheper, T. H. (2002) · Cytotechnology · doi:10.1023/a:1021170502775 · Cited by 125
Hypoxia Promotes Efficient Differentiation of Human Embryonic Stem Cells to Functional Endothelium
Prado‐Lòpez, S., Conesa, A., Armiñán, A., Martínez‐Losa, M., Escobedo‐Lucea, C., Gandía, C., Tarazona, S., Melguizo‐Sanchis, D., Blesa, D., Montaner, D. A., et al. (2010) · Stem Cells · doi:10.1002/stem.295 · Cited by 124
Lillehoj, H. S., Kim, D. K., Bravo, D. M., & Lee, S. H. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s4-s34 · Cited by 113
Rayment, E. A., & Williams, D. (2010) · Stem Cells · doi:10.1002/stem.416 · Cited by 105
Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures
Wu, J., Rostami, M. R., Olaya, D. P. C., & Tzanakakis, E. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102486 · Cited by 101
Assessing the Value of Autologous and Allogeneic Cells for Regenerative Medicine
Mason, C., & Dunnill, P. (2009) · Regenerative Medicine · doi:10.2217/rme.09.64 · Cited by 86
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Moll, G., Hult, A. K., von Bahr, L., Alm, J. J., Heldring, N., Hamad, O. A., Funke, L., Larsson, S., Teramura, Y., Roelofs, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085040 · Cited by 79
Manufacture of a human mesenchymal stem cell population using an automated cell culture platform
Thomas, R. J., Chandra, A., Liu, Y., Hourd, P. C., CONWAY, P. P., & Williams, D. (2007) · Cytotechnology · doi:10.1007/s10616-007-9091-2 · Cited by 79
A Decade of Cell Therapy Clinical Trials (2000–2010)
Culme-Seymour, E. J., Davie, N. L., Brindley, D. A., Edwards‐Parton, S., & Mason, C. (2012) · Regenerative Medicine · doi:10.2217/rme.12.45 · Cited by 67
Insights into large-scale cell-culture reactors: II. Gas-phase mixing and CO₂ stripping.
Sieblist, C., Hägeholz, O., Aehle, M., Jenzsch, M., Pohlscheidt, M., & Lübbert, A. (2011) · Biotechnology Journal · doi:10.1002/biot.201100153 · Cited by 65
Thomas, R. J., Hourd, P. C., & Williams, D. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.06.009 · Cited by 63
Regulatory challenges for the manufacture and scale-out of autologous cell therapies
Hourd, P., Chandra, A., Medcalf, N., & Williams, D. J. (2014) · StemBook · doi:10.3824/stembook.1.96.1 · Cited by 63
Human cell culture process capability: a comparison of manual and automated production
Liu, Y., Hourd, P. C., Chandra, A., & Williams, D. (2009) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.217 · Cited by 61
Evaluation of a novel Wave Bioreactor® cellbag for aerobic yeast cultivation
Mikola, M. R., Seto, J., & Amanullah, A. (2007) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-007-0119-y · Cited by 60
Precision manufacturing for clinical-quality regenerative medicines
Williams, D., Thomas, R. J., Hourd, P. C., Chandra, A., Ratcliffe, E., Liu, Y., Rayment, E. A., & Archer, J. R. (2012) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2011.0049 · Cited by 59
Thomas, R. J., Hope, A. D., Hourd, P. C., Baradez, M., Miljan, E., Sinden, J. D., & Williams, D. (2009) · Biotechnology Letters · doi:10.1007/s10529-009-9989-1 · Cited by 51
Kedong, S., Fan, X., Tianqing, L., Macedo, H., LiLi, J., Fang, M.-Y., Shi, F., Ma, X., & Zhanfeng, C. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4167-5 · Cited by 41
Regen: The Industry Responsible for Cell-Based Therapies
Mason, C., & Manzotti, E. (2009) · Regenerative Medicine · doi:10.2217/rme.09.72 · Cited by 34
From production to patient: challenges and approaches for delivering cell therapies
Coopman, K. (2014) · StemBook · doi:10.3824/stembook.1.97.1 · Cited by 32
Self-citationHuman embryonic stem cells: early hints on safety and efficacy
Atala, A. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60118-4 · Cited by 31
The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012
Mason, C., McCall, M., Culme-Seymour, E. J., Suthasan, S., Edwards‐Parton, S., Bonfiglio, G. A., & Reeve, B. C. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.11.013 · Cited by 29
Self-citationOxygen Transfer in Stirred Bioreactors Under Animal Cell Culture Conditions
Langheinrich, C., Nienow, A. W., Eddleston, T., Stevenson, N. C., Emery, A. N., Clayton, T. M., & Slater, N. K. H. (2002) · Food and Bioproducts Processing · doi:10.1205/096030802753479098 · Cited by 22
Self-citationMacDonald, C. M. L. A. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)30016-4 · Cited by 22
Mason, C., & Manzotti, E. (2010) · Regenerative Medicine · doi:10.2217/rme.10.74 · Cited by 20
The Translation Cycle: Round and Round in Cycles is the Only way Forward for Regenerative Medicine
Mason, C., & Manzotti, E. (2010) · Regenerative Medicine · doi:10.2217/rme.10.14 · Cited by 13
Kim, J. C., Seong, J. H., Lee, B., et al. (2013) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-012-0558-4 · Cited by 10
Cited by
Ho-Shui-Ling, A., Bolander, J., Rustom, L. E., Johnson, A. W., Luyten, F. P., & Picart, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.017 · Cited by 961
Clinical manufacturing of CAR T cells: foundation of a promising therapy
Wang, X., & Rivière, I. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.15 · Cited by 637
Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 397
Hofer, H. R., & Tuan, R. S. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0394-0 · Cited by 360
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency
Willis, G. R., Kourembanas, S., & Mitsialis, S. A. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00063 · Cited by 257
Metadata
- Authors
- Heathman, T. R., Nienow, A. W., McCall, M. J., Coopman, K., Kara, B., & Hewitt, C. J.
- Venue
- Regenerative Medicine
- Publisher
- Informa UK Limited
- Published
- 2015-01
- Volume
- 10
- Issue
- 1
- Pages
- 49-64
- ISSN
- 1746-0751 (ISSN-L)
- 1746-076X
- OpenAlex
- W2155825917
- Cited by
- 297
- References
- 66
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.